Literature DB >> 27999888

Imaging of autoimmune hepatitis and overlap syndromes.

Neera Malik1, Sudhakar K Venkatesh2.   

Abstract

Autoimmune hepatitis (AIH) is an uncommon, chronic inflammatory, and relapsing liver disease of unknown origin that may lead to liver cirrhosis, hepatocellular carcinoma, liver transplantation, or death. AIH occurs in all age groups and races but can frequently manifest as acute fulminant hepatitis. Clinical presentation of AIH can have features similar to primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC), and these diseases may coexist leading to overlap syndromes. Although histological diagnosis is necessary, imaging features often can demonstrate characteristics that may be helpful to distinguish these diseases. Imaging features of AIH are those of chronic liver disease, and imaging plays important role in detection of complications and ruling out other possible causes of chronic liver disease. Emerging techniques such as elastography provide non-invasive options for diagnosis of significant fibrosis and cirrhosis during clinical follow-up as well as assessment of response to treatment. In this study, we will describe imaging findings in AIH and overlap syndromes.

Entities:  

Keywords:  Autoimmune hepatitis; Cirrhosis; MR elastography; Primary biliary cirrhosis; Primary sclerosing cholangitis

Mesh:

Year:  2017        PMID: 27999888     DOI: 10.1007/s00261-016-1019-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  2 in total

Review 1.  Ultrasound findings in autoimmune hepatitis.

Authors:  Yi Dong; Andrej Potthoff; Christoph Klinger; Ana Paula Barreiros; Dariusz Pietrawski; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

2.  The role of diffusion tensor imaging of the liver in children with autoimmune hepatitis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Ahmed Megahed; Mohamed Elsayed Ahmed; Suzy Abd ElMabood; Rihame Abdel Wahab
Journal:  Pol J Radiol       Date:  2021-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.